Details for Patent: 12,138,199

Which drugs does patent 12,138,199 protect, and when does it expire?

Patent 12,138,199 protects MIUDELLA and is included in one NDA.

This patent has nine patent family members in seven countries.

Summary for Patent: 12,138,199

Title:	Intrauterine device with retrieval thread
Abstract:	An intrauterine contraceptive system may include a contraceptive intrauterine device, a retrieval thread permanently attached to the intrauterine device and an insertion device for inserting the intrauterine device into a uterus. The system may also include a release thread releasably coupled with the intrauterine device. The intrauterine device may be deployable out of a distal end of the insertion device and may be configured to change from a delivery configuration when housed in the insertion device to a deployed configuration when deployed in a uterus. The retrieval thread and the optional release thread may be at least partially housed within the insertion device during insertion of the intrauterine device into the uterus. The release thread may extend from the intrauterine device through the insertion device to an attachment point at or near a proximal end of the insertion device.
Inventor(s):	Michael Tal, Bob H. Katz, Mark James DeBisschop
Assignee:	Sebela Vlc Ltd
Application Number:	US18/357,253
Patent Claim Types: see list of patent claims	Composition; Compound; Delivery; Device;

Drugs Protected by US Patent 12,138,199

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Sebela Womens Hlth	MIUDELLA	copper	SYSTEM;INTRAUTERINE	218201-001	Feb 24, 2025		RX	Yes	Yes			Y

International Family Members for US Patent 12,138,199

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2014334816
Australia	2019200369
Brazil	112016008594